EP 1173468 A1 20020123 - INTEGRIN RECEPTOR ANTAGONISTS
Title (en)
INTEGRIN RECEPTOR ANTAGONISTS
Title (de)
INTEGRINREZEPTORANTAGONISTEN
Title (fr)
ANTAGONISTES RECEPTEURS D'INTEGRINE
Publication
Application
Priority
- DE 19919218 A 19990428
- DE 19948269 A 19991006
- EP 0003469 W 20000417
Abstract (en)
[origin: WO0066618A1] The invention relates to new compounds which bind to integrin receptors, as well as to their production, their use as integrin receptor antagonists and for the treatment of diseases, pharmaceutical preparations containing said compounds and pharmaceutical preparations containing at least one other active compound.
IPC 1-7
C07K 5/023; C07D 277/48; C07D 417/12; C07D 333/38; C07D 263/48; C07D 409/12; C07D 413/12; C07D 307/68; A61K 38/04; A61K 31/33; A61K 31/426; A61P 9/00
IPC 8 full level
A61K 31/27 (2006.01); A61K 31/381 (2006.01); A61K 31/421 (2006.01); A61K 31/426 (2006.01); A61K 31/4406 (2006.01); A61K 31/443 (2006.01); A61K 31/4439 (2006.01); A61K 45/00 (2006.01); A61K 45/06 (2006.01); A61P 3/10 (2006.01); A61P 3/14 (2006.01); C12N 9/99 (2006.01); A61P 7/02 (2006.01); A61P 9/00 (2006.01); A61P 9/04 (2006.01); A61P 9/08 (2006.01); A61P 9/10 (2006.01); A61P 13/12 (2006.01); A61P 17/02 (2006.01); A61P 17/06 (2006.01); A61P 19/02 (2006.01); A61P 19/08 (2006.01); A61P 19/10 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 33/00 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07C 275/42 (2006.01); C07D 207/34 (2006.01); C07D 213/56 (2006.01); C07D 249/14 (2006.01); C07D 263/34 (2006.01); C07D 263/48 (2006.01); C07D 277/20 (2006.01); C07D 277/48 (2006.01); C07D 277/56 (2006.01); C07D 307/68 (2006.01); C07D 333/38 (2006.01); C07D 333/40 (2006.01); C07D 401/12 (2006.01); C07D 409/12 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07K 5/02 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP KR)
A61K 45/06 (2013.01 - EP); A61P 3/10 (2018.01 - EP); A61P 3/14 (2018.01 - EP); A61P 7/02 (2018.01 - EP); A61P 9/00 (2018.01 - EP); A61P 9/04 (2018.01 - EP); A61P 9/08 (2018.01 - EP); A61P 9/10 (2018.01 - EP); A61P 13/12 (2018.01 - EP); A61P 17/02 (2018.01 - EP); A61P 17/06 (2018.01 - EP); A61P 19/02 (2018.01 - EP); A61P 19/08 (2018.01 - EP); A61P 19/10 (2018.01 - EP); A61P 29/00 (2018.01 - EP); A61P 31/04 (2018.01 - EP); A61P 31/12 (2018.01 - EP); A61P 33/00 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07D 263/34 (2013.01 - EP); C07D 277/48 (2013.01 - EP); C07D 307/68 (2013.01 - EP); C07D 333/38 (2013.01 - EP); C07D 409/12 (2013.01 - EP); C07D 413/12 (2013.01 - EP); C07D 417/12 (2013.01 - EP); C07K 5/02 (2013.01 - KR); C07K 5/0202 (2013.01 - EP); A61K 38/00 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0066618 A1 20001109; AU 4551500 A 20001117; BG 106040 A 20020531; BR 0010092 A 20020611; CA 2371604 A1 20001109; CN 1355811 A 20020626; CZ 20013846 A3 20020612; EP 1173468 A1 20020123; HK 1046692 A1 20030124; HU P0202898 A2 20021228; IL 146146 A0 20020725; JP 2003500339 A 20030107; KR 20020010618 A 20020204; MX PA01010834 A 20020424; NO 20015237 D0 20011026; NO 20015237 L 20011221; PL 352777 A1 20030908; RU 2001132141 A 20040320; SK 15342001 A3 20020604; TR 200103090 T2 20020521
DOCDB simple family (application)
EP 0003469 W 20000417; AU 4551500 A 20000417; BG 10604001 A 20011023; BR 0010092 A 20000417; CA 2371604 A 20000417; CN 00808907 A 20000417; CZ 20013846 A 20000417; EP 00926971 A 20000417; HK 02107883 A 20021030; HU P0202898 A 20000417; IL 14614600 A 20000417; JP 2000615647 A 20000417; KR 20017013790 A 20011027; MX PA01010834 A 20000417; NO 20015237 A 20011026; PL 35277700 A 20000417; RU 2001132141 A 20000417; SK 15342001 A 20000417; TR 200103090 T 20000417